GENEMEDIX PLC has a total of 15 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SHANGHAI KEXIN BIOTECH CO LTD, DANA FABER CANCER INST INC and DYAX CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Mexico | 1 | |
#7 | Poland | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Cui Dafu | 7 |
#2 | Ding Jinguo | 6 |
#3 | Zhang Youshang | 6 |
#4 | Shi Jaihao | 6 |
#5 | Wu Xiangfu | 5 |
#6 | Naihe Jing | 3 |
#7 | Mei Jin | 2 |
#8 | Jin Mei Lei | 1 |
Publication | Filing date | Title |
---|---|---|
AU2003246946A1 | Monomeric insulin |